Grubman Wealth Management »

Novo Nordisk A/S shares owned by Grubman Wealth Management

Quarter-by-quarter ownership of Novo Nordisk A/S (NVO) shares owned by Grubman Wealth Management from 13F filings

Historical chart of Grubman Wealth Management investment in Novo Nordisk A/S

Tip: Access up to 7 years of quarterly data

All positions including Novo Nordisk A/S held by Grubman Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novo Nordisk A/S by Grubman Wealth Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $253k 2.1k 119.07
2024-06-30 $303k 2.1k 142.74
2024-03-31 $275k 2.1k 129.33
2023-12-31 $217k 2.1k 103.45
2023-09-30 $209k 2.3k 90.94

More positions owned by Grubman Wealth Management

iShares Russell 1000 ETF Class Title (IWB)
iShares Russell 2000 ETF Class Title (IWM)
iShares 7-10 Year Treasury Bond ETF Class Title (IEF)
iShares MSCI EAFE ETF Class Title (EFA)
iShares Core US Aggregate Bond ETF Class Title (AGG)
Vanguard Mortgage-Backed Secs ETF Class Title (VMBS)
Invesco NASDAQ 100 ETF Class Title (QQQM)
iShares 0-5 Year TIPS Bond ETF Class Title (STIP)
Vanguard FTSE Developed Markets ETF Class Title (VEA)
Vanguard S&P 500 ETF Class Title (VOO)
Vanguard Small-Cap ETF Class Title (VB)
Vanguard Short-Term Corporate Bond ETF Class Title (VCSH)
iShares Core MSCI Emerging Markets ETF Class Title (IEMG)
iShares ESG Aware MSCI USA ETF Class Title (ESGU)
Vanguard Real Estate ETF Class Title (VNQ)

View all positions for Grubman Wealth Management

Top funds holding Novo Nordisk A/S

Jennison Associates
Morgan Stanley
Bank of America Corporation
Fisher Investments
Fayez Sarofim & Co
T. Rowe Price Associates
Folketrygdfondet
Renaissance Technologies
GQG Partners
Capital Research and Management Company - Division 3
Polen Capital Management
Everett Harris & Co
State Street Corporation
State Farm Mutual Automobile Insurance Company
BlackRock

View all funds holding Novo Nordisk A/S